Kratom bill 260163

A kratom user, she opposed the bill, urging regulation and science-based policy rather than a complete ban on natural kratom.

A chronic pain patient with degenerative disc disease, he said kratom and 7-OH restored his mobility and begged for regulation over prohibition.

Opposed the bill, arguing kratom and 7-OH are safe partial agonists that don't cause respiratory depression, and asked for age restrictions instead of a ban.

Ten years clean after a near-fatal overdose, he credited natural kratom with saving his life and urged age restrictions and testing standards instead of a ban.

Briefly opposed the kratom bill, saying pharmaceutical companies offer side effects while kratom offers relief; urged regulation, not a ban.

Opposed the bill, arguing tying legality to FDA approval structurally favors pharmaceutical corporations and would disproportionately hurt Black and brown residents.

A small business owner and chronic pain patient, 14 years clean, she said kratom and 7-OH save lives and urged focus on bigger community issues.

Speaking for the Global Kratom Coalition, she said the bill's synthetic-product provisions are good but its FDA requirements make it a de facto ban on natural kratom; asked Council to amend.

A West Philadelphia store manager selling whole-leaf kratom, he said the bill would be a de facto ban hurting invisible users who rely on it to avoid relapse.

Area manager for CBD Kratom, he said the bill would eliminate minor cannabinoids like CBG and CBN and conflates natural leaf with concentrated 7-OH; proposed lab testing and labeling rules instead.

A Northeast Philadelphia resident, he argued illegal activity in some smoke shops should be prosecuted, not used to ban lawful natural kratom.

Sixteen years sober, he credited kratom with helping him stay clean and urged regulation of synthetics rather than banning natural kratom.